C3J Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:C3J Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011929
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
C3J Therapeutics Inc (C3J), formerly C3 Jian Inc, is a clinical-stage biotechnology company which concentrates on the development and commercialization of targeted and pathogen specific, antimicrobials that treat and prevent diseases caused by microbial dysbiosis. Its pipeline product portfolio includes specifically targeted antimicrobial peptides (STAMP) such as C16G2 which is being developed for the prevention of dental caries; CD17-DL, a pipeline candidate used to treat difficle infection; PCR diagnostic tests and other discovery programs. C3J utilizes its specifically targeted antimicrobial peptides platform technology which allows the STAMP to reengineer the microbiota by selectively killing the targeted pathogen. C3J is headquartered in Los Angeles, California, the US.

C3J Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
C3J Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
C3J Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
C3J Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
C3J Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
C3J Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
C3J Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
C3J Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
C3J Therapeutics Raises USD19 Million in Venture Financing 11
C3 Jian Raises US$60 Million In Series D Financing 12
C3 Jian Raises US$30 Million In Venture Financing 13
Partnerships 14
C3 Jian And Sen Nuo Wei Biotech Enter Into Joint Venture Agreement With Sichuan University 14
Licensing Agreements 15
C3 Jian Enters into Licensing Agreement with Regents of the University of California 15
C3J Therapeutics Inc – Key Competitors 16
C3J Therapeutics Inc – Key Employees 17
C3J Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Mar 01, 2016: C3 Jian Announces Appointment of Biotech Veteran H. Stewart Parker as New Board Chair 19
Clinical Trials 20
Dec 12, 2016: C3J Therapeutics Unveils Development of Two New Product Formulations of Lead Candidate C16G2 for Prevention of Dental Caries 20
Other Significant Developments 21
Nov 29, 2016: C3 Jian announces names change to C3J Therapeutics 21
Nov 29, 2016: C3 Jian Announces Corporate Name Change and Expansion of Management Team 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
C3J Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
C3J Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
C3J Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
C3J Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
C3J Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
C3J Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
C3J Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
C3J Therapeutics Raises USD19 Million in Venture Financing 11
C3 Jian Raises US$60 Million In Series D Financing 12
C3 Jian Raises US$30 Million In Venture Financing 13
C3 Jian And Sen Nuo Wei Biotech Enter Into Joint Venture Agreement With Sichuan University 14
C3 Jian Enters into Licensing Agreement with Regents of the University of California 15
C3J Therapeutics Inc, Key Competitors 16
C3J Therapeutics Inc, Key Employees 17
C3J Therapeutics Inc, Subsidiaries 18

★海外企業調査レポート[C3J Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ig Group Holdings Plc:企業の戦略・SWOT・財務分析
    Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Westrock Co:企業の戦略・SWOT・財務分析
    Westrock Co - Strategy, SWOT and Corporate Finance Report Summary Westrock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Clinigen Group Plc (CLIN):企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • Southern Minnesota Municipal Power Agency:発電所・企業SWOT分析
    Southern Minnesota Municipal Power Agency - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …
  • University of Arizona-製薬・医療分野:企業M&A・提携分析
    Summary University of Arizona (UA) is a healthcare research university that offers undergraduate and graduate degrees. The university’s academic departments include cancer biology graduate interdisciplinary program, cancer biology, cellular and molecular medicine, cancer center, center for education …
  • OncoTherapy Science Inc (4564):企業の財務・戦略的SWOT分析
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Baoviet Holdings:企業の戦略・SWOT・財務分析
    Baoviet Holdings - Strategy, SWOT and Corporate Finance Report Summary Baoviet Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Penske Automotive Group, Inc.:企業の戦略・SWOT・財務情報
    Penske Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Penske Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • FuelCell Energy Inc (FCEL)-エネルギー分野:企業M&A・提携分析
    Summary FuelCell Energy, Inc. (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. It offers proprietary fuel cell products based on Direct FuelCell (DFC) carbonate fuel c …
  • TaiDoc Technology Corporation (4736):企業の財務・戦略的SWOT分析
    TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SP Transmission plc:企業の戦略的SWOT分析
    SP Transmission plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Ajinomoto Co Inc (2802):企業の財務・戦略的SWOT分析
    Ajinomoto Co Inc (2802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Tohoku Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Flynn Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Flynn Pharma Ltd (Flynn Pharma) is a pharmaceutical company that manufactures and markets barbiturate products, and oral and injectable antibiotics. The company’s products include cefuroxime, circadin, distaclor, keflex, medikinet tablets, medikinet XL capsules, nebcin, nizatidine, phenytoin …
  • Schlumberger Ltd (SLB)-石油・ガス分野:企業M&A・提携分析
    Summary Schlumberger Limited (Schlumberger) is an oilfield services company that provides technology for reservoir characterization, drilling, production, and processing to the oil and gas industry. Schlumberger also supplies the industries with products and services, from exploration through produc …
  • United Gulf Bank (B.S.C.):企業の戦略・SWOT・財務分析
    United Gulf Bank (B.S.C.) - Strategy, SWOT and Corporate Finance Report Summary United Gulf Bank (B.S.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Haisco Pharmaceutical Group Co Ltd (002653):製薬・医療:M&Aディール及び事業提携情報
    Summary Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations. The company offers parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive sy …
  • Performance Food Group:企業の戦略・SWOT・財務分析
    Performance Food Group - Strategy, SWOT and Corporate Finance Report Summary Performance Food Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • EyePoint Pharmaceuticals Inc (PSDV):企業の財務・戦略的SWOT分析
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. EyePoint dura …
  • Biogened SA-製薬・医療分野:企業M&A・提携分析
    Summary BIOGENED SA (Biogened) is a drug company that develops, produces, and distributes Rx medicines and dietary supplements. The company’s products include recipes dermocosmetic products, specialized products, active ingredients, pharmaceutical products, and cosmetic products. Its also offers nov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆